Comparison of a patient-specific, gradually progressive exercise program guided by clinical parameters with an eccentric exercise program in people with chronic mid portion achillestendinopathy;

Completed

Conditions: Achillestendinitis
10043237
overuse of the Achillestendon

Registration Number: NL-OMON42918

Lead Sponsor: Maxima Medisch Centrum

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 62

Inclusion Criteria

age* 18 jaar;
clinical diagnosis (pain, swelling, decreased function) of midportion achillestendinopathy (2-7 cm proximal to the insertion at the calcaneus);
complaints for 3 months or more.

Exclusion Criteria

Insertional tendinopathy of the achillespees;
not able to perform *heavy-load* excentric exercises;
Clinical suspicion of an acute (partial) rupture of the achilles tendon;
Previous surgical treatment of the Achilles tendon;
(Systemic) disease, that influence the prognosis and recovery (Diabetes Mellitus, Reumatoïd Disease, Artritis, OsteoArtritis of the knee/ankle/foot, lower leg or ankle injury).
Wash out period 6 weken (temporary exclusion)

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Difference in function (VISA-A) between the 2 exercise programs at 16 weeks<br /><br>compared to baseline</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>1) Function (VISA-A) at week 4, 8 and 12 compared to baseline<br /><br>2) Pain (NPRS average, best, worst, functional test) after 16 weeks compared to<br /><br>baseline<br /><br>3) Pain (NPRS) during the isometric exercises vs eccentric exercises<br /><br>3) Pain (NPRS) alteration just before and after the exercise therapy during the<br /><br>first 4 weeks<br /><br>4) Patiënt satisfaction (GPE) at 16 weeks<br /><br>5) Compliance (%) during the exercise program (16 weeks)<br /><br>6) Function (VISA-A) at the long term; at week 24, 36 and 52 compared to<br /><br>baseline<br /><br>7) Pain (NPRS) at the long term; at week 24, 36 and 52 compared to baseline</p><br>